Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Oral ivermectin is used off-label for stubborn Demodex blepharitis, but it is not the FDA-approved treatment for this eyelid condition. Here is what the research actually supports.
Ivermectin paralyzes parasites by locking open chloride channels found only in invertebrate nerves and muscles. Here is what that mechanism does and does not explain about its approved uses.
Ivermectin is the WHO-backed mainstay treatment for river blindness, controlling the disease and protecting sight through repeated, weight-based dosing.
Ivermectin is a genuine, well-studied antiparasitic, but its proven strength lies chiefly in one intestinal worm, Strongyloides, not all of them.
A clinical look at how ivermectin is absorbed, how long it stays active in the body, and what the evidence actually says about taking it with or without food.
Oral ivermectin is a well-studied, weight-dosed treatment for scabies used off-label alongside topical permethrin. Here is what the trials actually show and how it is properly dosed.
Ivermectin is the FDA-approved, first-line treatment for strongyloidiasis, backed by randomized trials showing superior cure rates over older drugs.
Topical ivermectin cream is an FDA-approved, well-studied rosacea treatment. Oral ivermectin tablets are not approved for this use, and that distinction matters.
Ivermectin is the cornerstone treatment for onchocerciasis (river blindness), backed by decades of trial data. Here is what the evidence shows, how dosing actually works, and what patients can realistically expect.